Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Harper

Showing results (491-500 of 522) with videos related to

Pageof 53
Sort By:
Open Heart|April 11, 2018
Clinical presentation of CIED infection following initial implant versus reoperation for generator change or lead additionMariko W Harper, Daniel Z Uslan, Arnold J Greenspon, et al.
Journal of Medicinal Chemistry|January 14, 2017
Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide LinkerJames R Corte, Tianan Fang, Honey Osuna, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2008
Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagoguesAndrés S Hernández, Stephen G Swartz, Dorothy Slusarchyk, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2020
Orally bioavailable amine-linked macrocyclic inhibitors of factor XIaTianan Fang, James R Corte, Paul J Gilligan, et al.
Cancer Research|June 27, 2019
<i>EN1</i> Is a Transcriptional Dependency in Triple-Negative Breast Cancer Associated with Brain MetastasisGuillermo Peluffo, Ashim Subedee, Nicholas W Harper, et al.
Cancer Immunology Research|April 21, 2022
Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast CancerCarlos R Gil Del Alcazar, Anne Trinh, Maša Alečković, et al.
Bioorganic & Medicinal Chemistry|April 14, 2016
Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime groupJames R Corte, Tianan Fang, Donald J P Pinto, et al.
Nature Communications|December 8, 2022
Breast cancer prevention by short-term inhibition of TGFβ signalingMaša Alečković, Simona Cristea, Carlos R Gil Del Alcazar, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2017
Macrocyclic inhibitors of Factor XIa: Discovery of alkyl-substituted macrocyclic amide linkers with improved potencyJames R Corte, Wu Yang, Tianan Fang, et al.
Journal of Medicinal Chemistry|November 2, 2001
Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable I(Ks) blockersJ Lloyd, J B Schmidt, G Rovnyak, et al.
Pageof 53

Showing results (491-500 of 522) with videos related to

Sort By:
Pageof 53
Open Heart|April 11, 2018
Clinical presentation of CIED infection following initial implant versus reoperation for generator change or lead additionMariko W Harper, Daniel Z Uslan, Arnold J Greenspon, et al.
Journal of Medicinal Chemistry|January 14, 2017
Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide LinkerJames R Corte, Tianan Fang, Honey Osuna, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2008
Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagoguesAndrés S Hernández, Stephen G Swartz, Dorothy Slusarchyk, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2020
Orally bioavailable amine-linked macrocyclic inhibitors of factor XIaTianan Fang, James R Corte, Paul J Gilligan, et al.
Cancer Research|June 27, 2019
<i>EN1</i> Is a Transcriptional Dependency in Triple-Negative Breast Cancer Associated with Brain MetastasisGuillermo Peluffo, Ashim Subedee, Nicholas W Harper, et al.
Cancer Immunology Research|April 21, 2022
Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast CancerCarlos R Gil Del Alcazar, Anne Trinh, Maša Alečković, et al.
Bioorganic & Medicinal Chemistry|April 14, 2016
Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime groupJames R Corte, Tianan Fang, Donald J P Pinto, et al.
Nature Communications|December 8, 2022
Breast cancer prevention by short-term inhibition of TGFβ signalingMaša Alečković, Simona Cristea, Carlos R Gil Del Alcazar, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2017
Macrocyclic inhibitors of Factor XIa: Discovery of alkyl-substituted macrocyclic amide linkers with improved potencyJames R Corte, Wu Yang, Tianan Fang, et al.
Journal of Medicinal Chemistry|November 2, 2001
Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable I(Ks) blockersJ Lloyd, J B Schmidt, G Rovnyak, et al.
Pageof 53